Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.12.13
2012年第三次临时股东大会决议公告
2012.12.13
2012年第三次临时股东大会的法律意见书
2012.11.30
关于更换保荐代表人的公告
2012.11.24
中国中投证券有限责任公司关于公司拟调整募集资金投资项目投资进度的核查意见
2012.11.24
关于变更会计师事务所的公告
2012.11.24
第二届监事会第十九次会议决议公告
2012.11.24
关于召开2012年第三次临时股东大会的通知公告
2012.11.24
关于调整募投项目投资进度的公告
2012.11.24
第二届董事会第二十一次会议决议公告
2012.11.07
关于承诺履行情况的公告
第一页
上一页
131
132
133
134
135
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
